Literature DB >> 20363992

Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway.

Halvor Naess1, Endre Sundal, Kjell-Morten Myhr, Harald Inge Nyland.   

Abstract

BACKGROUND: We aimed to compare patients reporting acute infection with those reporting no infection at onset of chronic fatigue syndrome (CFS). PATIENTS AND METHODS: This study includes 873 patients with CFS referred to a tertiary centre on average 4.8 years after symptom onset. Assessment was by both observer query and self-reports. Antibody analyses against infectious agents including Epstein-Barr virus and enterovirus were performed in a majority of patients.
RESULTS: Females comprised 75.3% of the patient group, and the mean age was 33 years. Initial infection was reported by 77%. There was no difference as to antibody analyses. Logistic regression showed that initial infection was independently associated with acute onset of fatigue, improvement of fatigue at referral, and the following symptoms at referral: fever, tender lymph nodes, and myalgia.
CONCLUSION: CFS patients with initial infection as a precipitating factor more often report acute onset of fatigue, more frequent accompanying symptoms, and more frequent improvement on referral than do patients without initial infection.

Entities:  

Mesh:

Year:  2010        PMID: 20363992

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  12 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  Symptom reporting in a general population in Norway: results from the Ullensaker study.

Authors:  Mona Kjeldsberg; Hedda Tschudi-Madsen; Ingvild Dalen; Jørund Straand; Dag Bruusgaard; Bård Natvig
Journal:  Scand J Prim Health Care       Date:  2013-01-07       Impact factor: 2.581

3.  Epipharyngeal Abrasive Therapy (EAT) Has Potential as a Novel Method for Long COVID Treatment.

Authors:  Kazuaki Imai; Takafumi Yamano; Soichiro Nishi; Ryushiro Nishi; Tatsuro Nishi; Hiroaki Tanaka; Toshiyuki Tsunoda; Shohei Yoshimoto; Ayaki Tanaka; Kenji Hiromatsu; Senji Shirasawa; Takashi Nakagawa; Kensuke Nishi
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

4.  Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence.

Authors:  Halvor Naess; Morten Nyland; Trygve Hausken; Inghild Follestad; Harald I Nyland
Journal:  BMC Gastroenterol       Date:  2012-02-08       Impact factor: 3.067

5.  Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.

Authors:  Øystein Fluge; Ove Bruland; Kristin Risa; Anette Storstein; Einar K Kristoffersen; Dipak Sapkota; Halvor Næss; Olav Dahl; Harald Nyland; Olav Mella
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

6.  Fatigue in adults with post-infectious fatigue syndrome: a qualitative content analysis.

Authors:  Eva Stormorken; Leonard A Jason; Marit Kirkevold
Journal:  BMC Nurs       Date:  2015-11-28

7.  Longitudinal follow-up of employment status in patients with chronic fatigue syndrome after mononucleosis.

Authors:  Morten Nyland; Halvor Naess; Jon Steinar Birkeland; Harald Nyland
Journal:  BMJ Open       Date:  2014-11-26       Impact factor: 2.692

8.  Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults' experiences.

Authors:  Eva Stormorken; Leonard A Jason; Marit Kirkevold
Journal:  BMC Public Health       Date:  2017-12-13       Impact factor: 3.295

9.  From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults' experiences of the illness trajectory.

Authors:  Eva Stormorken; Leonard A Jason; Marit Kirkevold
Journal:  BMC Fam Pract       Date:  2017-03-27       Impact factor: 2.497

Review 10.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.

Authors:  Gerwyn Morris; George Anderson; Piotr Galecki; Michael Berk; Michael Maes
Journal:  BMC Med       Date:  2013-03-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.